NuSil Technology is a leading formulator of silicone compounds for aerospace, healthcare, electronics, and other applications requiring precise, predictable, cost-effective materials performance. ISO-9001 certified since 1994, NuSil operates state-of-the-art laboratories and processing facilities in both North America and Europe and provides on-site, in-person application engineering support worldwide. Earlier this year, the company announced the acquisition of Rhodia Silicones’ long-term implantable silicones business. Long-term implantable silicones are used in medical device products implanted for 29-days or more. Drug Delivery Technology interviewed Richard A. Compton, NuSil’s President & Chief Executive Officer, on how this acquisition demonstrates NuSil’s continued commitment to the healthcare industry, further strengthening its leading position as the supplier of choice for medical device manufacturers worldwide.
View Full Article